Premium
The Use of Monoamine Oxidase Inhibitors in the Treatment of Elderly, Depressed Patients
Author(s) -
Jenike Michael A.
Publication year - 1984
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1984.tb06134.x
Subject(s) - medicine , monoamine oxidase , depression (economics) , monoamine neurotransmitter , psychiatry , monoamine oxidase inhibitor , refractory (planetary science) , pharmacology , serotonin , enzyme , receptor , astrobiology , economics , macroeconomics , biochemistry , chemistry , physics
Depression is an extremely common illness in the elderly, and Is, at times, refractory to the usual therapies. The elderly are also particularly prone to develop toxic side effects from standard antidepressive agents. Monoamine oxidase inhibitors are rarely used in this population, although much evidence and clinical experience would indicate that they can be extremely effective and non‐toxic. This paper outlines the indications and precautions for use and side effects of monoamine oxidase inhibitors in the treatment of depression in elderly patients.